Two affiliated Chinese drug manufacturers targeted by forthcoming US national security legislation are working on sales of some of their operations, according to people familiar with the matter.
據知情人士透露，兩家受即將出臺的美國國家安全立法針對的中國關聯製藥企業正在著手出售部分業務。
您已閱讀4%（240字），剩餘96%（5596字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。